| Code | Target | Indication | Preclinical | Ph I | Ph II | Ph III | NDA/BLA | Detail |
|---|
| UB202 | Lanosterol 14-alpha demethylase | Invasive aspergillosis; Mucormycosis | |
|
| UB422 | Neuroprotective | Cerebrovascular accident | |
|
| UB082 | F protein (RSV) | Respiratory syncytial virus infection | | About |
| UB395 | CDK2/4/6 | Breast cancer metastatic; Liposarcoma; Lung cancer metastatic | |
|
| UB314 | EGFR (L858R) | Non-small cell lung cancer | |
|
| UB360 | P2Y12R | Peripheral arterial disease | | About |
| UB429 | Steroid + VD | Psoriasis | |
|
| UB361 | JAK1 (oral) | Atopic dermatitis | | About |
| UB312 | GLP-1 (oral) | Obesity; Overweight | |
|
| UB313 | GLP-1 (oral) | Diabetes mellitus | |
|
| UB353 | SYK inhibitor | Immune thrombocytopenia | |
|
| UB518 | voltage-gated sodium channel | Detoxification | |
|
| UB521 | P2Y12R | Cerebrovascular accident | | About |
| UB063 | HBV Caspid | Chronic hepatitis B | | About |
| UB068 | JAK1 (oral) | Ankylosing spondylitis | | About |
| UB428 | PDE4 | Psoriasis; Atopic dermatitis | |
|
| UB309 | JAK1; JAK2 | Vitiligo | |
|
| UB362 | JAK1 (oral) | Vitiligo | | About |
| UB310 | JAK1; JAK2 | Prurigo nodularis | |
|
| UB348 | Surface Antigen HBsAg | Hepatitis B | |
|
| UB386 | AT2R | Post-stroke pain | |
|
| UB042 | 5-HT; DA | Autism spectrum disorder; Atrial septal defect; Acute stress disorder | | About |
| UB024 | KV1.3 (Topical) | Atopic dermatitis | | About |
| UB062 | KCNQ2/3 | Epilepsy | | About |
| UB067 | JAK1 (Gel) | Atopic dermatitis | | About |
| UB561 | TYK2 | Atopic dermatitis; Inflammatory bowel disease | |
|
| UB519 | voltage-gated sodium channel | Analgesia | |
|
| UB347 | Core Protein CpAM | Hepatitis B | |
|
| UB027 | mTORC2 | Neuroendocrine tumour; Lung cancer; Breast cancer | |
|
| UB028 | FXIa | Thrombus | |
|
| UB147 | Keratin; Plasmin |
| |
|
| UB388 | AR | Metastatic castration-resistant prostate cancer | |
|
| UB349 | ASK-1 | Nonalcoholic steatohepatitis; Hepatic fibrosis | |
|
| UB363 | JAK1 (oral) | Inflammatory bowel disease | | About |
| UB387 | BTK | Haematological malignancy | |
|
| UB376 | GLP-1R | Obesity | |
|
| UB364 | JAK1 (oral) | Rheumatoid arthritis | | About |
| UB083 | F protein (RSV) | Respiratory syncytial virus infection prophylaxis | | About |
| UB069 | RIPK1 | Peripheral arterial disease; Primary biliary cholangitis | | About |
| UB064 | TEAD | Malignant neoplasm | | About |
| UB026 | PI3K-Akt-mTOR pathway | Malignant melanoma; Oesophageal cancer; Colorectal cancer | |
|
| UB497 |
| Cervical intraepithelial neoplasia | |
|
| UB176 | KV1.3 (Topical) | Psoriasis | | About |
| UB509 | IDH1 mutation | Low grade glioma; Cholangiocarcinoma; Chondrosarcoma | |
|
| UB524 | MYC | Solid tumour; Haematologic malignancy; Pancreatic ductal adenocarcinoma; Hepatocellular carcinoma; Brain neoplasm malignant; Prostate cancer; Colorectal cancer; Gastric cancer; Acute myeloid leukaemia; Multiple myeloma; Lymphoma | |
|
| UB177 | KV1.3 (Oral) | Atopic dermatitis | | About |
| UB520 | THR-β | Obesity; Metabolic dysfunction-associated steatohepatitis | | About |
| UB029 | KV1.3 (Oral) | Inflammatory bowel disease | | About |
| UB523 | RdRp Inhibitor | Respiratory tract infection | |
|
| UB522 | immune modulator | Hepatitis B chronic | |
|
| UB284 | AChE | Myasthenia gravis | |
|
| UB366 | TRKA/B/C | Solid tumour | | About |
| UB389 | ER | Breast cancer | |
|
| UB398 | Pan KRAS | Solid tumour | |
|
| UB400 | PARP1 | Solid tumour; Brain metastases | |
|
| UB404 | MENIN | Haematological malignancy | |
|
| UB030 | cMyc pathway | Gynaecological neoplasm | |
|
| UB148 | Androgen receptor |
| |
|
| UB365 | TRKA (Gel) | Skin inflammation; Pruritus | | About |
| UB401 | USP1 | Solid tumour | |
|
| UB040 | Multiple targets; immunostimulants | Malignant neoplasm | |
|
| UB183 | Ion channel inhibitor | Diabetic nephropathy | | About |
| UB066 | P2Y12R | Ischaemic stroke | | About |
| UB043 | Agmatinase; Imidazoline Rc; NMDA Rc | Atrial septal defect; Autism spectrum disorder; Acute stress disorder | | About |
| UB065 | P2Y12R | Acute coronary syndrome | | About |
| UB070 | pan-RAS (on) | Solid tumour | | About |
| UB179 | GPCR | Diabetic retinopathy; Age-related macular degeneration | | About |
| UB181 | GPCR | Chronic obstructive pulmonary disease | | About |
| UB180 | GPCR | Ocular inflammation | | About |
| UB413 |
| Retinoblastoma | |
|
| UB370 | ATM | Solid tumour | |
|
| UB367 | IL-17A/F | Psoriasis | |
|
| UB372 | WRN | Solid tumour | |
|
| UB369 | ER-PROTAC | Breast cancer | |
|
| UB125 | GABAA Receptor | Epilepsy | |
|
| UB182 | Ion channel inhibitor | Pruritus | | About |
| UB178 | KV1.3 (Topical) | Alopecia | | About |
| UB371 | MAT2A | Solid tumour | |
|
| UB368 | BTK-PROTAC | Systemic lupus erythematosus; Atopic dermatitis | |
|
| UB374 |
| Diabetes mellitus; Obesity | |
|
| UB399 | Pan RAS | Solid tumour | |
|
| UB375 |
| Weight decreased | |
|
| UB379 | AMYR | Obesity; Diabetes mellitus | |
|
| UB381 | STAT6 | Autoimmune disorder; Respiratory disorder | |
|
| UB380 | GIPR | Diabetes mellitus | |
|
| UB373 | TL1A | Inflammatory bowel disease | |
|
| UB378 | ActRIIA/B | Obesity | |
|
| UB564 | ALK | Solid tumour | |
|
| UB562 | DPP-1/CTSK | Bronchiectasis | |
|
| UB407 | WFS1 | Solid tumour | |
|
| UB405 | BTK | Chronic lymphocytic leukaemia; Small lymphocytic lymphoma; Diffuse large B-cell lymphoma | |
|
